[go: up one dir, main page]

IL162827A0 - A process for producing phenserine and its analog - Google Patents

A process for producing phenserine and its analog

Info

Publication number
IL162827A0
IL162827A0 IL16282702A IL16282702A IL162827A0 IL 162827 A0 IL162827 A0 IL 162827A0 IL 16282702 A IL16282702 A IL 16282702A IL 16282702 A IL16282702 A IL 16282702A IL 162827 A0 IL162827 A0 IL 162827A0
Authority
IL
Israel
Prior art keywords
phenserine
analog
producing
compounds
isocyanate
Prior art date
Application number
IL16282702A
Other languages
English (en)
Original Assignee
Axonyx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axonyx Inc filed Critical Axonyx Inc
Publication of IL162827A0 publication Critical patent/IL162827A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL16282702A 2002-01-09 2002-12-11 A process for producing phenserine and its analog IL162827A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/042,586 US6495700B1 (en) 2002-01-09 2002-01-09 Process for producing phenserine and its analog
PCT/US2002/039537 WO2003059909A1 (fr) 2002-01-09 2002-12-11 Processus de production de phenserine et de ses analogues

Publications (1)

Publication Number Publication Date
IL162827A0 true IL162827A0 (en) 2005-11-20

Family

ID=21922704

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16282702A IL162827A0 (en) 2002-01-09 2002-12-11 A process for producing phenserine and its analog

Country Status (15)

Country Link
US (1) US6495700B1 (fr)
EP (1) EP1463729B1 (fr)
JP (1) JP2005514459A (fr)
KR (2) KR20060097772A (fr)
CN (1) CN1301995C (fr)
AT (1) ATE466015T1 (fr)
AU (1) AU2002353102B2 (fr)
BR (1) BRPI0215492A2 (fr)
CA (1) CA2470560C (fr)
DE (1) DE60236207D1 (fr)
HR (1) HRP20040606A2 (fr)
HU (1) HUP0500747A3 (fr)
IL (1) IL162827A0 (fr)
PL (1) PL374240A1 (fr)
WO (1) WO2003059909A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1689704A2 (fr) 2003-10-21 2006-08-16 CoLucid Pharmaceuticals, Inc. Esters de carbamoyle inhibant la cholinesterase et liberant des agents pharmacologiquement actifs
WO2006138385A2 (fr) * 2005-06-14 2006-12-28 Cancog Technologies Inc.24 Utilisation de la phenserine et de ses analogues pour traiter des troubles de comportement et ameliorer la capacite d'apprentissage
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP2258359A3 (fr) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenèse par modulation des récepteurs muscariniques avec sabcomeline
CA2662491A1 (fr) * 2006-09-08 2008-03-13 Braincells, Inc. Combinaisons contenant un derive de 4-acylaminopyridine
CN109662964A (zh) 2010-02-09 2019-04-23 约翰斯.霍普金斯大学 用于改善认知功能的方法和组合物
US20120225922A1 (en) 2011-03-04 2012-09-06 Qr Pharma Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
US20130096316A1 (en) * 2011-10-14 2013-04-18 Qr Pharma, Inc. Novel Method for Preparation of Bisnorcymerine and Salts Thereof
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
WO2014144663A1 (fr) 2013-03-15 2014-09-18 The Johns Hopkins University Procédés et compositions pour améliorer la fonction cognitive
CN105142623A (zh) 2013-03-15 2015-12-09 艾吉因生物股份有限公司 用于改善认知功能的方法和组合物
NZ738682A (en) 2015-05-22 2022-01-28 Agenebio Inc Extended release pharmaceutical compositions of levetiracetam
US12042482B2 (en) 2015-08-14 2024-07-23 Annovis Bio, Inc. Methods of treatment or prevention of acute brain or nerve injuries
US20180338950A1 (en) 2017-05-24 2018-11-29 Qr Pharma, Inc. Prevention or Treatment of Disease States Due to Metal Dis-Homeostasis Via Administration of Posiphen to Healthy or Sick Humans

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1109003B (it) * 1977-09-20 1985-12-16 Univ Firenze Derivati dell 1 2 3 8 3 a 8 a esai dropirrolo 23 b indolo
IT1199076B (it) 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione
US5306825A (en) 1984-03-01 1994-04-26 Consiglio Nazionale Delle Ricerche Physostigmine derivatives with acetylcholinesterase inhibition properties, and the relative production process
US4791107A (en) 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
IT1225462B (it) * 1987-04-03 1990-11-14 Mediolanum Farmaceutici Srl Sali organici di derivati della fisostigmina
US5187165A (en) 1987-05-15 1993-02-16 Hoechst-Roussel Pharmaceuticals Inc. Memory enhancing and analgesic 1,2,3a,8,8a-hexahydro-3a,8(and 1,3a,8)-di(and tri)methylpyrrolo[2,3-b]indoles
US4900748A (en) 1988-03-04 1990-02-13 The United States Of America As Represented By The Department Of Health And Human Services Carbamates related to (-)-physostigmine as cholinergic agents
US5260452A (en) 1989-11-03 1993-11-09 Hoechst-Roussel Pharmaceuticals Inc. 4- and 6-carbamates related to physostigmine and intermediates for the preparation thereof
US5177101A (en) 1989-11-30 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
US5077289A (en) 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
US5705657A (en) 1991-02-14 1998-01-06 Labochim Laboratorio Chimico Internazionale S.P.A. Isocyanate process for the preparation of 1,3A,8-trimethyl-1,2,3,3A, 8, 8A-hexahydro-pyrrole 2,3-B! indol-5 (3AS, 8AR) -hepthylcarbamate
EP0499959A1 (fr) 1991-02-18 1992-08-26 Bromine Compounds Ltd. Procédé pour la préparation des maléimides substitués
WO1993006105A1 (fr) 1991-09-26 1993-04-01 United States Government, As Represented By Secret Phenserines et phenylcarbamates substitues de (-)-eseroline, (-)-n1-noreseroline, et (-)-n1-benzylnoreseroline utilises comme inhibiteurs specifiques de l'acetylcholinesterase
US5206260A (en) 1991-11-07 1993-04-27 Merck & Co., Inc. Hexahydropyrrolo[2,3-b]indole derivatives
US5302721A (en) 1992-07-21 1994-04-12 Hoechst-Roussel Pharmaceuticals Incorporated Method of preparation of physostigmine carbamate derivatives from eseretholes
FI990752L (fi) * 1992-07-21 1999-04-06 Hoechst Marion Roussel Inc Menetelmä fysostigmiinikarbamaattijohdannaisten valmistamiseksi fysostigmiinistä
US5409948A (en) 1992-11-23 1995-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for treating cognitive disorders with phenserine
US5665880A (en) 1996-10-31 1997-09-09 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseretholes
US5677457A (en) 1996-12-19 1997-10-14 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseroline ethers

Also Published As

Publication number Publication date
EP1463729B1 (fr) 2010-04-28
AU2002353102B2 (en) 2007-05-24
EP1463729A1 (fr) 2004-10-06
DE60236207D1 (de) 2010-06-10
CA2470560C (fr) 2007-05-15
KR100712003B1 (ko) 2007-05-02
HRP20040606A2 (en) 2004-12-31
ATE466015T1 (de) 2010-05-15
HUP0500747A3 (en) 2009-05-28
CN1301995C (zh) 2007-02-28
PL374240A1 (en) 2005-10-03
KR20060097772A (ko) 2006-09-15
JP2005514459A (ja) 2005-05-19
US6495700B1 (en) 2002-12-17
CA2470560A1 (fr) 2003-07-24
KR20040072711A (ko) 2004-08-18
CN1612880A (zh) 2005-05-04
HK1075659A1 (en) 2005-12-23
BRPI0215492A2 (pt) 2016-07-05
EP1463729A4 (fr) 2005-06-29
AU2002353102A1 (en) 2003-07-30
HUP0500747A2 (hu) 2005-11-28
WO2003059909A1 (fr) 2003-07-24

Similar Documents

Publication Publication Date Title
IL162827A0 (en) A process for producing phenserine and its analog
MXPA04006677A (es) Procedimiento para la preparacion de esteres de escopina.
WO2007001385A3 (fr) Procede permettant de preparer des 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
CY1108866T1 (el) Βελτιωμενη μεθοδος για την παρασκευη ενωσεων 3-υδροξυ-4-υδροξυμεθυλ-πυρρολιδινης
UA89390C2 (ru) Способ получения аннелированных производных пиперазин-2-она та соответствующие промежуточные продукты
TNSN05105A1 (en) Novel bicyclic inhibitors of hormone sensitive lipase
WO2006067456A3 (fr) Processus chimiques
MXPA04007396A (es) Proceso para la elaboracion de inhibidores de reductasa hmg-coa.
IL162817A0 (en) Process for the manufacture of organic compounds
MXPA05008183A (es) Proceso para preparar pirrolotriazina como inhibidores de cinasa.
WO2004043918A3 (fr) Nouvelles formes cristallines d'atorvastatine hemi-calcium et leurs procedes de preparation ainsi que de nouveaux procedes de preparation d'autres formes
IL174469A0 (en) Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
GB2454629A (en) Pyrrolo[2, 1-C][1, 4]benzodiazepine hybrids and a process for the preparation thereof
AU2003267565A8 (en) Process for the production of a fuel composition
IL175253A0 (en) A process for preparing pyrrole derivatives
GB0010475D0 (en) Organic compounds
WO2007096903A3 (fr) Nouvelle forme cristalline d'hemi-calcium d'atorvastatine
MY145842A (en) Method of producing triethanolamine
UA85428C2 (ru) Способ получения с-2, с-3 замещенных n-алкилированных индолов, а также промежуточные соединения и способы их получения
WO2006036926A3 (fr) Synthese efficace de 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
TW200626606A (en) Process for preparing phosphorus compounds having phosphate-phosphonate bond
SG146645A1 (en) Process for the synthesis of 6-amino-4-(3-chloro-4fluoro-phenylamino)-7- ethoxy-quinoline-3-carbonitrile
TW200942546A (en) A crystalline form of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one
GB2425309A (en) C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers
TW200630369A (en) Process for preparing purine compounds